Literature DB >> 4622109

Functional evaluation of prolactin secretion: a guide to therapy.

H Friesen, H Guyda, P Hwang, J E Tyson, A Barbeau.   

Abstract

Stimulation and inhibition tests are proposed for evaluating prolactin secretion. Thyrotropin-releasing hormone (TRH) stimulates the release of prolactin from the pituitary. Chlorpromazine acts presumably at the hypothalamic level to increase prolactin secretion. L-Dopa (D,L-alpha-hydrazino-alpha-methyl-beta-[3,4-di-hydroxyphenyl]) has the opposite effect; it inhibits prolactin secretion and may be effective in suppressing galactorrhea.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4622109      PMCID： PMC302176          DOI： 10.1172/JCI106859

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  10 in total

1.  Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture.

Authors:  A H Tashjian; N J Barowsky; D K Jensen
Journal:  Biochem Biophys Res Commun       Date:  1971-05-07       Impact factor: 3.575

2.  The hypothalamus, brain-catecholamines, and drug therapy for gigantism and acromegaly.

Authors:  L Sherman; H D Kolodny
Journal:  Lancet       Date:  1971-04-03       Impact factor: 79.321

3.  Hypophysial portal vessel infusion: in vivo demonstration of LRF, FRF, and PIF in pituitary stalk plasma.

Authors:  I A Kamberi; R S Mical; J C Porter
Journal:  Endocrinology       Date:  1971-10       Impact factor: 4.736

4.  Levodopa suppression of prolactin in nonpuerperal galactorrhea.

Authors:  W B Malarkey; L S Jacobs; W H Daughaday
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Prolactin-dependent rat mammary cancer: a model for man?

Authors:  O H Pearson; O Llerena; L Llerena; A Molina; T Butler
Journal:  Trans Assoc Am Physicians       Date:  1969

6.  Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide.

Authors:  C Y Bowers; H G Friesen; P Hwang; H J Guyda; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1971-11       Impact factor: 3.575

7.  Syntheses of pyroglutamylhistidylprolinamide and unusual mass fragmentation.

Authors:  J K Chang; H Sievertsson; C Bogentoft; B Currie; K Folkers; G D Daves
Journal:  J Med Chem       Date:  1971-06       Impact factor: 7.446

8.  Activity and specificity of synthetic thyrotropin-releasing hormone in man.

Authors:  C Y Bowers; A V Schally; D S Schalch; C Gual; A J Kastin; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1970-05-11       Impact factor: 3.575

9.  Synthetic thyrotropin-releasing hormone. Activity in men and women, specificity of action, inhibition by triiodothyronine, and activity orally.

Authors:  C Y Bowers; A V Schally; A Kastin; A Arimura; D S Schalch; C Gual; E Castineda; K Folkers
Journal:  J Med Chem       Date:  1971-06       Impact factor: 7.446

10.  A radioimmunoassay for human prolactin.

Authors:  P Hwang; H Guyda; H Friesen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205
  10 in total
  17 in total

1.  The effect of levodopa on galactorrhea in the Forbes-Albright syndrome.

Authors:  M Edmonds; H Friesen
Journal:  Can Med Assoc J       Date:  1972-09-23       Impact factor: 8.262

Review 2.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

3.  Hypothyroidism presenting with hyperprolactinaemia.

Authors:  C G Semple; G H Beastall; G Teasdale; J A Thomson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09

4.  The effect on plasma prolactin, growth hormone and luteinising hormone concentrations of single oral doses or propranolol and tolamolol in normal man.

Authors:  C A Saxton; J K Faulkner; G V Groom
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Serum prolactin and progesterone concentrations in ovulatory infertility.

Authors:  T Ranta; P Lehtovirta; U H Stenman; M Seppälä
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

6.  Inhibition of thyrotropin and prolactin secretion by dopamine in man.

Authors:  F Massara; F Camanni; V Vergano; L Belforte; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

7.  Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Authors:  G M Besser; L Parke; C R Edwards; I A Forsyth; A S McNeilly
Journal:  Br Med J       Date:  1972-09-16

8.  Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

Authors:  S A Fine; L A Frohman
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

9.  Effects of L-dopa on plasma levels of parathyroid hormone in calves.

Authors:  J W Blum; D Schams; W Born; M Da Prada
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

10.  The synaptic significance of metoclopramide induced dyskinetic-dystonic head and neck movements in pregnancy.

Authors:  J J Askenasy; M Streifler; S Felner
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.